Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Comparative protective effects of HI-6 and MMB-4 against organophosphorous nerve agent poisoning.

Lundy PM, Hamilton MG, Sawyer TW, Mikler J.

Toxicology. 2011 Jul 29;285(3):90-6. doi: 10.1016/j.tox.2011.04.006. Epub 2011 Apr 15. Review.

PMID:
21524678
2.

Substantially improved pharmacokinetics of recombinant human butyrylcholinesterase by fusion to human serum albumin.

Huang YJ, Lundy PM, Lazaris A, Huang Y, Baldassarre H, Wang B, Turcotte C, Côté M, Bellemare A, Bilodeau AS, Brouillard S, Touati M, Herskovits P, Bégin I, Neveu N, Brochu E, Pierson J, Hockley DK, Cerasoli DM, Lenz DE, Wilgus H, Karatzas CN, Langermann S.

BMC Biotechnol. 2008 May 16;8:50. doi: 10.1186/1472-6750-8-50.

3.
4.

Medical countermeasures to WMDs: defence research for civilian and military use.

Hamilton MG, Lundy PM.

Toxicology. 2007 Apr 20;233(1-3):8-12. Epub 2006 Sep 1.

PMID:
17029736
5.

The pharmacokinetics and pharmacodynamics of two HI-6 salts in swine and efficacy in the treatment of GF and soman poisoning.

Lundy PM, Hill I, Lecavalier P, Hamilton MG, Vair C, Davidson C, Weatherby KL, Berger BJ.

Toxicology. 2005 Mar 30;208(3):399-409.

PMID:
15695025
6.

Clinical aspects of percutaneous poisoning by the chemical warfare agent VX: effects of application site and decontamination.

Hamilton MG, Hill I, Conley J, Sawyer TW, Caneva DC, Lundy PM.

Mil Med. 2004 Nov;169(11):856-62.

PMID:
15605929
7.

Pharmacological differentiation of the P2X7 receptor and the maitotoxin-activated cationic channel.

Lundy PM, Nelson P, Mi L, Frew R, Minaker S, Vair C, Sawyer TW.

Eur J Pharmacol. 2004 Mar 8;487(1-3):17-28.

PMID:
15033372
8.

Stimulation of Ca(2+) influx through ATP receptors on rat brain synaptosomes: identification of functional P2X(7) receptor subtypes.

Lundy PM, Hamilton MG, Mi L, Gong W, Vair C, Sawyer TW, Frew R.

Br J Pharmacol. 2002 Apr;135(7):1616-26.

9.

A comparison of the effects of sarin and succinylcholine on respiratory parameters in anesthetized domestic swine.

Duncan EJ, Conley JD, Grychowski KD, Conley SA, Lundy PM, Hamilton MG, Sawyer TW.

Mil Med. 2001 Apr;166(4):322-7.

PMID:
11315472
10.

Modification of cytosolic free calcium concentrations in human keratinocytes after sulfur mustard exposure.

Hamilton MG, Dorandeu FM, McCaffery M, Lundy PM, Sawyer TW.

Toxicol In Vitro. 1998 Aug;12(4):365-72.

PMID:
20654418
11.
12.

Protective effect of an inhibitor of nitric oxide synthase on sulphur mustard toxicity in vitro.

Sawyer TW, Lundy PM, Weiss MT.

Toxicol Appl Pharmacol. 1996 Nov;141(1):138-44.

PMID:
8917686
13.

Review: Ca2+ channel sub-types in peripheral efferent autonomic nerves.

Lundy PM, Frew R.

J Auton Pharmacol. 1996 Oct;16(5):229-41. Review. No abstract available.

PMID:
9023667
14.
15.

Effect of ruthenium red on voltage-sensitive Ca++ channels.

Hamilton MG, Lundy PM.

J Pharmacol Exp Ther. 1995 May;273(2):940-7.

PMID:
7538585
16.

Effect of omega-agatoxin-IVA on autonomic neurotransmission.

Lundy PM, Frew R.

Eur J Pharmacol. 1994 Aug 11;261(1-2):79-84.

PMID:
8001657
17.

Pharmacological identification of a novel Ca2+ channel in chicken brain synaptosomes.

Lundy PM, Hamilton MG, Frew R.

Brain Res. 1994 Apr 18;643(1-2):204-10.

PMID:
8032915
18.

Identification of noradrenaline in venom from the funnel-web spider Hololena curta.

Frew R, Hamilton MG, Lundy PM.

Toxicon. 1994 Apr;32(4):511-5.

PMID:
8053004
19.
20.

Pharmacological characterization of voltage-sensitive Ca2+ channels in autonomic nerves.

Lundy PM, Frew R.

Eur J Pharmacol. 1993 Feb 9;231(2):197-202.

PMID:
7681004
21.
22.

Comparison of several oximes against poisoning by soman, tabun and GF.

Lundy PM, Hansen AS, Hand BT, Boulet CA.

Toxicology. 1992;72(1):99-105.

PMID:
1539175
23.

Pharmacological evidence for an omega-conotoxin, dihydropyridine-insensitive neuronal Ca2+ channel.

Lundy PM, Frew R, Fuller TW, Hamilton MG.

Eur J Pharmacol. 1991 Jan 25;206(1):61-8.

PMID:
1648498
24.

The effect of neuropeptide Y on voltage-sensitive Ca2+ channels.

Lundy PM, Frew R.

Eur J Pharmacol. 1991 Jan 17;192(3):439-41.

PMID:
2055242
25.

Failure of adenosine analogues to affect N-type voltage sensitive Ca2+ channels in chicken brain synaptosomes.

Lundy PM, Frew R, Hamilton MG.

Biochem Pharmacol. 1990 Aug 1;40(3):651-4. No abstract available.

PMID:
2166520
26.

Distribution of the bispyridinium oxime [14C] HI-6 in male and female rats.

Lundy PM, Hand BT, Broxup BR, Yipchuck G, Hamilton MG.

Arch Toxicol. 1990;64(5):377-82.

PMID:
2403289
27.

Effect of endothelin on Ca2+ influx, intracellular free Ca2+ levels and ligand binding to N and L type Ca2+ channels in rat brain.

Hamilton MG, Frew R, Lundy PM.

Biochem Biophys Res Commun. 1989 Aug 15;162(3):1332-8.

PMID:
2548495
28.

Hormone- and dose schedule-dependent protection by HI-6 against soman and tabun poisoning.

Lundy PM, Goulet JC, Hand BT.

Fundam Appl Toxicol. 1989 Apr;12(3):595-603.

PMID:
2659414
29.

Effect of ?-conotoxin GVIA on Ca(2+) influx and endogenous acetylcholine release from chicken brain preparations.

Lundy PM, Stauderman K, Goulet JC, Frew R.

Neurochem Int. 1989;14(1):49-54.

PMID:
20504398
30.

HI-6 therapy of soman and tabun poisoning in primates and rodents.

Hamilton MG, Lundy PM.

Arch Toxicol. 1989;63(2):144-9.

PMID:
2730339
31.
32.
33.

Differential effects of ketamine isomers on neuronal and extraneuronal catecholamine uptake mechanisms.

Lundy PM, Lockwood PA, Thompson G, Frew R.

Anesthesiology. 1986 Mar;64(3):359-63.

PMID:
3954131
34.

Ketamine: evidence of tissue specific inhibition of neuronal and extraneuronal catecholamine uptake processes.

Lundy PM, Gverzdys S, Frew R.

Can J Physiol Pharmacol. 1985 Apr;63(4):298-303.

PMID:
3924378
35.

Evidence of reduced uptake of convulsant in brain following prostaglandin E2.

Lundy PM, Frew R.

Prostaglandins. 1984 May;27(5):725-35.

PMID:
6589687
37.

Modification of cholinergically induced convulsive activity and cyclic GMP levels in the CNS.

Lundy PM, Shaw RK.

Neuropharmacology. 1983 Jan;22(1):55-63. No abstract available.

PMID:
6302545
38.
39.
40.
41.

Mechanism of action of ketamine.

Lundy PM.

Br J Anaesth. 1980 Jun;52(6):638. No abstract available.

42.

Ganglion blocking properties of some bispyridinium soman antagonists.

Lundy PM, Tremblay KP.

Eur J Pharmacol. 1979 Nov 23;60(1):47-53.

PMID:
42547
43.

The ganglionic blocking properties of the cholinesterase reactivator, HS-6.

Lundy PM.

Can J Physiol Pharmacol. 1978 Oct;56(5):857-62.

PMID:
30527
44.

Gamma aminobutyric acid metabolism in different areas of rat brain at the onset of soman-induced convulsions.

Lundy PM, Magor G, Shaw RK.

Arch Int Pharmacodyn Ther. 1978 Jul;234(1):64-73. No abstract available.

PMID:
708144
45.

Mechanism of the cardiovascular activity of dibenzoxazepine in cats.

Lundy PM.

Eur J Pharmacol. 1978 Apr 1;48(3):271-9.

PMID:
639855
46.

Cyclic GMP concentrations in cerebellum following organophosphate administration.

Lundy PM, Magor GF.

J Pharm Pharmacol. 1978 Apr;30(4):251-2. No abstract available.

PMID:
24717
47.

The actions of ketamine on vascular smooth muscle.

Lundy PM, Gowdey CW, Colhoun EH.

Arch Int Pharmacodyn Ther. 1976 Apr;220(2):213-30.

PMID:
952582
48.

Further experimental evidence for a smooth muscle depressant effect of ketamine.

Lundy PM, Gowdey CW, Colhoun EH.

Arch Int Pharmacodyn Ther. 1975 Jul;216(1):57-62.

PMID:
1164106
49.

Experimental coronary artery ligation in conscious dogs six months after bilateral cardiac sympathectomy.

Fowlis RA, Sang CT, Lundy PM, Ahuja SP, Colhoun H.

Am Heart J. 1974 Dec;88(6):748-57. No abstract available.

PMID:
4423811
50.

Tracheal smooth muscle relaxant effect of ketamine.

Lundy PM, Gowdey CW, Colhoun EH.

Br J Anaesth. 1974 May;46(5):333-6. No abstract available.

Supplemental Content

Loading ...
Support Center